Andrea Charles | 06/18/2013
In this interview Christine Brideau, Executive Director, Biological Sample Management at Merck, speaks to Andrea Charles from Pharma IQ, about how biological sample management is now being addressed in the discovery space and the lack of retention policies for biological samples. Brideau also shares her top tips for establishing a consistent and holistic management system for biological samples and discusses the importance of risk reduction and emergency preparedness....
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 01 - 03, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More